STAT3 and cancer: Additional active molecules as potent chemoattractants for MDSCs emanate from studies showing that pro-inflammatory proteins S100A8 and S100A9 as the downstream targets of STAT3, a transcription factor regulating cancer cell proliferation and survival, were implicated in an autocrine pathway for the accumulation of MDSC in tumors and metastatic sites [25,26,27].